Vitamin D in the etiopathogenesis of autoimmune thyroiditis;Udział witaminy D w etiopatogenezie autoimmunologicznego zapalenia tarczycy

Polski Merkuriusz Lekarski

Volumn 34, Issue 203, 2013, Pages 281-285

  Lacka K ^a   Maciejewski, A ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Student Scientific Society   (Poland)

Author keywords

Autoimmune thyroiditis; Vitamin D

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL RECEPTOR; VITAMIN D; VITAMIN D BINDING PROTEIN;

AUTOIMMUNE THYROIDITIS; GENETIC POLYMORPHISM; GENETICS; HUMAN; METABOLISM; REVIEW; VITAMIN D DEFICIENCY;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; THYROIDITIS, AUTOIMMUNE; VITAMIN D; VITAMIN D DEFICIENCY; VITAMIN D-BINDING PROTEIN;

EID: 84879385110     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Arnson Y., Amital H., Shoenfeld, Y.: Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann. Rheum. Dis., 2007;66(9);1137-1142. (Pubitemid 47309727)
2. Ban Y., Taniyama M., Ban Y.: Vitamin D receptor gene polymorphisms in Hashimoto's thyroiditis. Thyroid., 2001;11(6);607-608. (Pubitemid 32578722)
3. Bemiss C. J., Mahon B. D., Henry A. et al.: Interleukin-2 is one of the targets of 1, 25-dihydroxyvitamin D3 in the immune system. Arch. Biochem. Biophys., 2002;402(2);249-254. (Pubitemid 34848643)
4. Boonstra A., Barrat F. J., Crain C. et al.: 1alpha, 25-Dihydroxyvitamin D3 has a direct effect on naive CD4 (+) T cells to enhance the development of Th2 cells. J. Immunol., 2001;167(9);4974-4980. (Pubitemid 33009728)
5. Camurdan O. M., Doger E., Bideci A. et al.: Vitamin D status in children with Hashimoto's thyroiditis. J. Pediatr. Endocrinol. Metab., 2012;25 (5-6);467-470.
6. Cantorna M. T., Hayes C. E., De Luca H. F.: 1, 25- Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J. Nutr., 1998;128(1);68-72. (Pubitemid 28087178)
7. Cantorna M. T., Munsick C., Bemiss C. et al.: 1, 25- Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr., 2000;130(11);2648-2652.
8. Chen S., Sims G. P., Chen X. X. et al.: Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol., 2007;179(3);1634-1647.
9. Cross H. S.: Extrarenal vitamin D hydroxylase expression and activity in normal and malignant cells: modification of expression by epigenetic mechanisms and dietary substances. Nutr. Rev., 2007;65(8);108-112.
10. Dobrzańska A. i wsp.: Polskie zalecenia dotycza̧ce profilaktyki niedoborów witaminy D - 2009. Pol. Merk. Lek., 2010;28(164);130-133.
11. Fang Y., Van Meurs J. B., D'Alesio A. et al.: Promoter and 3'-untranslatedregion haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study. Am. J. Hum. Genet., 2005;77(5);807-823. (Pubitemid 41513282)
12. Figueroa-Vega N., Alfonso-Pérez M., Benedicto I. et al.: Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab., 2010;95(2);953-962.
13. Fournier C., Gepner P., Sadouk M. et al.: In vivo beneficial effects of cyclosporin A and 1, 25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis. Clin. Immunol. Immunopathol., 1990;54(1);53-63. (Pubitemid 20024668)
14. Fritsche J., Mondal K., Ehrnsperger A. et al.: Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha, 25-dihydroxyvitamin D3 by human dendritic cells. Blood., 2003;102(9);3314-3316. (Pubitemid 37314772)
15. Goswami R., Marwaha R. K., Gupta N. et al.: Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey. Br. J. Nutr., 2009;102(3);382-386.
16. Joshi S., Pantalena L. C., Liu X. K. et al.: 1, 25-dihydroxyvitamin D (3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol. Cell Biol., 2011;31(17);3653-3669.
17. Kamen D. L., Tangpricha V.: Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J. Mol. Med. (Berl)., 2010;88(5);441-450.
18. Kivity S., Agmon-Levin N., Zisappl M. et al.: Vitamin D and autoimmune thyroid diseases. Cell Mol. Immunol., 2011;8(3);243-247.
19. Lin W. Y., Wan L., Tsai C. H. et al.: Vitamin D receptor gene polymorphisms are associated with risk of Hashimoto's thyroiditis in Chinese patients in Taiwan. J. Clin. Lab. Anal., 2006;20(3);109-112. (Pubitemid 43830452)
20. Lopez E. R., Zwermann O., Segni M. et al.: A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. Eur. J. Endocrinol., 2004;151(2);193-197. (Pubitemid 39207014)
21. Ła̧cka K., Maciejewski A.: Współczesne pogla̧dy na temat etiopatogenezy autoimmunologicznego zapalenia tarczycy (choroby Hashimoto). Pol. Merk. Lek., 2011;30(176);132-138.
22. Mahon B. D., Wittke A., Weaver V. et al.: The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J. Cell Biochem., 2003;89(5);922-932. (Pubitemid 36927724)
23. Matilainen J. M., Räsänen A., Gynther P. et al.: The genes encoding cytokines IL-2, IL-10 and IL-12B are primary 1 alpha, 25 (OH) 2D3 target genes. J. Steroid. Biochem. Mol. Biol., 2010;121 (1-2);142-145.
24. Mattner F., Smiroldo S., Galbiati F. et al.: Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1, 25-dihydroxyvitamin D (3). Eur. J. Immunol., 2000;30(2);498-508. (Pubitemid 30098842)
25. Monkawa T., Yoshida T., Hayashi M. et al.: Identification of 25-hydroxyvitamin D3 1 alpha-hydroxylase gene expression in macrophages. Kidney Int., 2000;58(2);559-568. (Pubitemid 30620005)
26. Pani M. A., Regulla K., Segni M. et al.: A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab., 2002;87(6);2564-2567. (Pubitemid 34655314)
27. Pierrot-Deseilligny C., Rivaud-Péchoux S., Clerson P. et al.: Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation. Ther. Adv. Neurol. Disord., 2012;5(4);187-198.
28. Staeva-Vieira T. P., Freedman L. P.: 1, 25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J. Immunol., 2002;168(3);1181-1189. (Pubitemid 34094483)
29. Stefanić M., Papić S., Suver M. et al.: Association of vitamin D receptor gene 3'-variants with Hashimoto's thyroiditis in the Croatian population. Int. J. Immunogenet., 2008;35(2);125-131. (Pubitemid 351347779)
30. Tamer G., Arik S., Tamer I. et al.: Relative vitamin D insufficiency in Hashimoto's thyroiditis. Thyroid., 2011;21(8);891-896.
31. Van Etten E., Branisteanu D. D., Overbergh L. et al.: Combination of a 1, 25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone. Bone., 2003;32(4);397-404. (Pubitemid 36407540)
32. Veldman C. M., Cantorna M. T., De Luca H. F.: Expression of 1, 25-dihydroxyvitamin D (3) receptor in the immune system. Arch. Biochem. Biophys., 2000;374(2);334-338. (Pubitemid 30120270)
33. Wang S. Y., Tung Y. C., Tsai W. Y. et al.: Long-term outcome of hormonal status in Taiwanese children with Hashimoto's thyroiditis. Eur. J. Pediatr., 2006;165(7);481-483.
34. Zella J. B., McCary L. C., De Luca H. F.: Oral administration of 1, 25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch. Biochem. Biophys., 2003;417(1);77-80. (Pubitemid 36960051)
35. Zhu Y., Mahon B. D., Froicu M. et al.: Calcium and 1 alpha, 25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur. J. Immunol., 2005;35(1);217-224. (Pubitemid 40123868)
36. Zipitis C. S., Akobeng A. K.: Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch. Dis. Child., 2008;93(6);512-517. (Pubitemid 352025770)